Headline News about Astellas Pharma Inc![]() ![]() Via Benzinga
![]() ![]() Via Benzinga
![]()
Astellas' Menopause Drug Under FDA Review
August 18, 2022
Via Benzinga
![]() Via Benzinga
![]()
Sutro Biopharma Stock Surges On Cancer Treatment Pact
June 28, 2022
Via Benzinga
![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
4 No-Brainer Pharmaceutical Stocks to Buy in October
September 27, 2021
Via Talk Markets
Exposures
COVID-19
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial
August 11, 2021
Via Benzinga
Exposures
Product Safety
![]()
The IPO Recap – Party Is Everything But Over
July 28, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Astellas Pharma Inc (OP: ALPMY )Headline News about Astellas Pharma Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|